IMMIX BIOPHARMA INC (IMMX) Stock Earnings & Estimates
USA - NASDAQ:IMMX - US45258H1068 - Common Stock
3.23 USD
-0.01 (-0.31%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 132.35% | N/A 37.97% | N/A 32.11% | N/A 18.06% | |||||||
| EBITDA YoY % growth | -840K | -450K 46.43% | -1.35M -200.00% | -8.22M -508.89% | -16.136M -96.30% | -22.642M -40.32% | N/A -2.27% | N/A -20.66% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -840K | -450K 46.43% | -1.35M -200.00% | -8.22M -508.89% | -16.141M -96.36% | -22.675M -40.48% | N/A -6.22% | N/A -19.17% | N/A 188.14% | N/A 244.13% | N/A 84.22% | N/A 44.06% | N/A 23.92% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -0.88 -76.55% | N/A 14.46% | N/A 8.54% | N/A -11.85% | N/A 209.93% | N/A 228.92% | N/A 38.83% | N/A 37.99% | N/A 18.55% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 19.25% | -0.17 -8.38% | -0.17 -15.60% | -0.17 21.18% | -0.17 10.53% | -0.19 -11.76% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.503M 12.07% | -6.705M -34.46% | -6.945M -48.31% | -7.193M -7.08% | -7.576M -16.50% | -8.177M -21.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.22 -46.67% | -0.16 | -0.06 | -34.80% |
| Q1 2025 Q2Q % growth | -0.15 36.06% | -0.23 | 0.08 | 36.06% |
| Q4 2024 Q2Q % growth | -0.16 30.43% | -0.26 | 0.10 | 37.25% |
| Q3 2024 Q2Q % growth | -0.24 -4.35% | -0.16 | -0.08 | -47.06% |
| Q2 2024 Q2Q % growth | -0.15 37.50% | -0.21 | 0.06 | 29.97% |
| Q1 2024 Q2Q % growth | -30.33% | -0.23 | % | |
| Q4 2023 Q2Q % growth | -0.23 14.81% | -0.23 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.23 | -0.23 | 0.00 | 1.96% |
| Q2 2023 Q2Q % growth | -0.24 | -0.17 | -0.07 | -38.41% |
| Q1 2023 Q2Q % growth | -0.18 | -0.14 | -0.04 | -26.05% |
| Q4 2022 Q2Q % growth | -0.27 | -0.22 | -0.05 | -20.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -18.75% | 0% | -13.45% |
| Revenue | N/A | N/A | N/A | N/A |